Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Susmita Roy

Mpharm (Pharmacology)

Susmita Roy, B pharm, M pharm Pharmacology, graduated from Gurunanak Institute of Pharmaceutical Science and Technology with a bachelor's degree in Pharmacy. She is currently working as an assistant professor at Haldia Institute of Pharmacy in West Bengal. She has been part of Medical Dialogues since March 2021.

Home

Susmita Roy

Articles By : Susmita Roy

Pharma Firm, Director Under ED Lens Over Alleged Rs 60 Crore PNB Fraud

Susmita Roy13 Aug 2025 7:40 PM IST

New Delhi: As a part of an alleged multi-crore bank fraud, the Directorate of Enforcement (ED), Chandigarh, has begun investigating Ankur Drugs and...

NPPA Expert Committee Recommends Pricing for Abbott's Clarithromycin Tablet, Cautions Firm Over Form Error

Susmita Roy13 Aug 2025 6:22 PM IST

New Delhi: The Multidisciplinary Committee (MDC) of the National Pharmaceutical Pricing Authority (NPPA) has recommended fixing the retail price of...

CDSCO Panel Approves Emcures Phase III Clinical Trial of Semaglutide, Mandates Govt Trial Sites

Emcure Pharma Gets CDSCO Panel Nod for Phase III Trial of Semaglutide in Chronic Weight Management

Susmita Roy13 Aug 2025 5:39 PM IST

New Delhi: Accepting the bioequivalence (BE) study report, the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control...

AIOCD Opposes Karnataka's Third-Party Pharmacy Inspection Plan, Warns of Legal, Data Risks

Susmita Roy12 Aug 2025 1:55 PM IST

New Delhi: Raising a deep concern regarding the proposal for third-party inspections in pharmacies through agencies such as the Quality Council of...

Precise Biopharma Gets CDSCO Panel Nod To Conduct Phase III Trial of Semaglutide Injection

Susmita Roy12 Aug 2025 12:47 PM IST

New Delhi: Accepting the bioequivalence study report, the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control...

No More Physical WHO-GMP Certificate Applications After August 15: DCGI Alerts Pharma Firms

Susmita Roy11 Aug 2025 5:45 AM IST

New Delhi: Reaffirming that no further extensions will be granted, the Drugs Controller General of India (DCGI), Central Drugs Standard Control...

Abiogenesis Clinpharm To Conduct Phase III Trial of UTI Drug Phenazopyridine

Susmita Roy10 Aug 2025 11:15 AM IST

New Delhi: The Subject Expert Committee (SEC), functional under the Central Drugs Standard Control Organisation (CDSCO), has granted approval to...

Novo Nordisks Wegovy, Fiasp, Ryzodeg Injectables Stolen During Transit, DCGI Issues Alert

CDSCO Panel Approves New Indications for Novo Nordisk's Semaglutide, Mandates PMS Study

Susmita Roy9 Aug 2025 12:18 PM IST

New Delhi: Recommending to conduct post marketing surveillance (PMS) study in India, the Subject Expert Committee (SEC) functional under the Central...

Pfizer Gets Expert Panel Nod to Update Etanercept Pre-Filled Injection Label

Susmita Roy8 Aug 2025 2:08 PM IST

New Delhi: Following a thorough review of post-marketing safety data, published literature, and clinical trial findings, the Subject Expert Committee...

CDSCO Panel Asks Unique Biotech to Submit Approval Status of Bacillus coagulans Unique IS-2 2 Billion CFU

CDSCO Committee Asks Elevate Scientific To Prove Back Pain Gel In Indian Trial

Susmita Roy7 Aug 2025 11:55 PM IST

New Delhi: With an aim to demonstrate the safety and efficacy on lower back pain, the Subject Expert Committee (SEC) functioning under the Central...

CDSCO Launches One-Year Online Dual Use NOC System for Bulk Drug Imports

CDSCO issues Revised Export NOC Guidance document for Manufacture of Unapproved, Approved New Drugs

Susmita Roy9 May 2025 6:00 PM IST

New Delhi: Through a recent notice, the Central Drugs Standard Control Organisation (CDSCO) has issued revised guidance documents for the issuance of...

NPPA Fixes Prices of 42 Popular Drugs Including Empagliflozin & Metformin, Dapagliflozin & Glimepiride; Details

NPPA Fixes Ceiling Price Of 9 Scheduled Formulations, Details

Susmita Roy8 May 2025 5:45 PM IST

New Delhi: Through a recent notification, the National Pharmaceutical Pricing Authority (NPPA) has fixed the ceiling price of 9 scheduled formulations...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok